ArticleJournal of clinical medicine2026

Outcomes and Prognostic Factors of Cetuximab-Based Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma.

Melike Dönmez Tekin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.